-
IBBQ Dashboard
- Holdings
Invesco Nasdaq Biotechnology ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 8.52 mm | 8.52 mm shares | 20.73 | Short-term investment vehicle | Long | USA |
GILD Gilead Sciences, Inc. | 4.05 mm | 43.78 k shares | 9.87 | Common equity | Long | USA |
Invesco Private Government Fund | 3.31 mm | 3.31 mm shares | 8.07 | Short-term investment vehicle | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 3.26 mm | 6.97 k shares | 7.94 | Common equity | Long | USA |
AMGN Amgen Inc. | 2.93 mm | 10.37 k shares | 7.14 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 2.19 mm | 2.91 k shares | 5.32 | Common equity | Long | USA |
AstraZeneca PLC, ADR
|
1.65 mm | 24.43 k shares | 4.02 | Common equity | Long | UK |
ALNY Alnylam Pharmaceuticals, Inc. | 1.36 mm | 5.38 k shares | 3.31 | Common equity | Long | USA |
BIIB Biogen Inc. | 982.89 k | 6.12 k shares | 2.39 | Common equity | Long | USA |
ILMN Illumina, Inc. | 962.92 k | 6.68 k shares | 2.34 | Common equity | Long | USA |
ARGX argenx SE | 834.19 k | 1.35 k shares | 2.03 | Common equity | Long | Netherlands |
MRNA Moderna, Inc. | 694.60 k | 16.13 k shares | 1.69 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 693.93 k | 1.87 k shares | 1.69 | Common equity | Long | USA |
VTRS Viatris Inc. | 654.38 k | 49.99 k shares | 1.59 | Common equity | Long | USA |
INCY Incyte Corporation | 602.46 k | 8.08 k shares | 1.47 | Common equity | Long | USA |
SNY Sanofi | 593.71 k | 12.24 k shares | 1.45 | Common equity | Long | France |
SMMT Summit Therapeutics Inc. | 560.15 k | 30.34 k shares | 1.36 | Common equity | Long | USA |
INSM Insmed Incorporated | 541.60 k | 7.21 k shares | 1.32 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 536.41 k | 4.23 k shares | 1.31 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 533.89 k | 4.00 k shares | 1.30 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 526.59 k | 7.98 k shares | 1.28 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 500.49 k | 18.77 k shares | 1.22 | Common equity | Long | UK |
BNTX BioNTech SE | 485.75 k | 4.10 k shares | 1.18 | Common equity | Long | Germany |
MEDP Medpace Holdings, Inc. | 441.80 k | 1.30 k shares | 1.08 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 441.61 k | 4.68 k shares | 1.07 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 436.06 k | 11.96 k shares | 1.06 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 405.35 k | 7.01 k shares | 0.99 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 401.41 k | 1.87 k shares | 0.98 | Common equity | Long | Cayman Islands |
ROIV Roivant Sciences Ltd. | 393.77 k | 30.98 k shares | 0.96 | Common equity | Long | Bermuda |
ITCI Intra-Cellular Therapies, Inc. | 379.17 k | 4.43 k shares | 0.92 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 331.08 k | 2.43 k shares | 0.81 | Common equity | Long | Denmark |
JAZZ Jazz Pharmaceuticals plc | 315.53 k | 2.60 k shares | 0.77 | Common equity | Long | Ireland |
Madrigal Pharmaceuticals, Inc. | 297.67 k | 907.00 shares | 0.72 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 255.80 k | 5.31 k shares | 0.62 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 255.79 k | 2.65 k shares | 0.62 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 255.77 k | 4.93 k shares | 0.62 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 240.35 k | 2.49 k shares | 0.59 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 238.48 k | 1.21 k shares | 0.58 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 219.13 k | 6.13 k shares | 0.53 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 213.66 k | 7.89 k shares | 0.52 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 211.36 k | 4.91 k shares | 0.51 | Common equity | Long | USA |
Alkermes Plc | 200.21 k | 6.90 k shares | 0.49 | Common equity | Long | Ireland |
ACLX Arcellx, Inc. | 198.86 k | 2.26 k shares | 0.48 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 196.83 k | 2.00 k shares | 0.48 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 196.29 k | 9.76 k shares | 0.48 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 191.85 k | 3.35 k shares | 0.47 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 184.09 k | 3.87 k shares | 0.45 | Common equity | Long | USA |
GH Guardant Health, Inc. | 183.46 k | 5.15 k shares | 0.45 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 182.42 k | 3.57 k shares | 0.44 | Common equity | Long | Switzerland |
APLS Apellis Pharmaceuticals, Inc. | 173.21 k | 5.11 k shares | 0.42 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 173.12 k | 6.14 k shares | 0.42 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 158.33 k | 2.55 k shares | 0.39 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 150.00 k | 6.00 k shares | 0.37 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 147.08 k | 29.18 k shares | 0.36 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 143.67 k | 3.42 k shares | 0.35 | Common equity | Long | Cayman Islands |
PTCT PTC Therapeutics, Inc. | 141.25 k | 3.22 k shares | 0.34 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 140.99 k | 2.37 k shares | 0.34 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 138.04 k | 3.21 k shares | 0.34 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 135.36 k | 5.20 k shares | 0.33 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 135.35 k | 3.18 k shares | 0.33 | Common equity | Long | Canada |
SRRK Scholar Rock Holding Corporation | 133.82 k | 3.35 k shares | 0.33 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 129.53 k | 3.93 k shares | 0.32 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 129.42 k | 3.12 k shares | 0.32 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 128.90 k | 4.21 k shares | 0.31 | Common equity | Long | USA |
MRUS Merus N.V. | 128.02 k | 2.86 k shares | 0.31 | Common equity | Long | Netherlands |
KYMR Kymera Therapeutics, Inc. | 126.50 k | 2.70 k shares | 0.31 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 123.96 k | 12.42 k shares | 0.30 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 120.84 k | 2.46 k shares | 0.29 | Common equity | Long | USA |
VCEL Vericel Corporation | 119.88 k | 2.06 k shares | 0.29 | Common equity | Long | USA |
VRNA Verona Pharma plc | 119.76 k | 3.02 k shares | 0.29 | Common equity | Long | UK |
IOVA Iovance Biotherapeutics, Inc. | 118.54 k | 12.72 k shares | 0.29 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 114.28 k | 2.30 k shares | 0.28 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 113.33 k | 6.94 k shares | 0.28 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 108.14 k | 2.47 k shares | 0.26 | Common equity | Long | USA |
GERN Geron Corporation | 104.07 k | 25.26 k shares | 0.25 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 98.47 k | 2.18 k shares | 0.24 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 96.83 k | 3.54 k shares | 0.24 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 94.78 k | 3.46 k shares | 0.23 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 93.09 k | 2.90 k shares | 0.23 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 92.88 k | 13.14 k shares | 0.23 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 92.59 k | 2.05 k shares | 0.23 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 92.20 k | 759.00 shares | 0.22 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 92.12 k | 1.99 k shares | 0.22 | Common equity | Long | USA |
NVCR NovoCure Limited | 91.00 k | 4.54 k shares | 0.22 | Common equity | Long | Jersey |
KROS Keros Therapeutics, Inc. | 90.88 k | 1.57 k shares | 0.22 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 85.42 k | 1.89 k shares | 0.21 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 84.40 k | 2.31 k shares | 0.21 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 83.61 k | 1.59 k shares | 0.20 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 82.68 k | 2.49 k shares | 0.20 | Common equity | Long | Cayman Islands |
HRMY Harmony Biosciences Holdings, Inc. | 82.24 k | 2.37 k shares | 0.20 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 79.05 k | 5.24 k shares | 0.19 | Common equity | Long | Singapore |
IRON Disc Medicine, Inc. | 79.00 k | 1.25 k shares | 0.19 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc. | 78.94 k | 3.75 k shares | 0.19 | Common equity | Long | USA |
MNKD MannKind Corporation | 78.10 k | 11.52 k shares | 0.19 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 76.71 k | 2.87 k shares | 0.19 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 70.60 k | 5.49 k shares | 0.17 | Common equity | Long | USA |
XNCR Xencor, Inc. | 66.51 k | 2.60 k shares | 0.16 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 66.46 k | 4.26 k shares | 0.16 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 65.01 k | 8.67 k shares | 0.16 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 64.62 k | 6.53 k shares | 0.16 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 63.95 k | 4.90 k shares | 0.16 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 61.98 k | 1.48 k shares | 0.15 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 61.74 k | 3.80 k shares | 0.15 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 60.23 k | 3.20 k shares | 0.15 | Common equity | Long | USA |
Zai Lab Ltd., ADR
|
60.21 k | 2.09 k shares | 0.15 | Common equity | Long | Cayman Islands |
NRIX Nurix Therapeutics, Inc. | 59.56 k | 2.69 k shares | 0.14 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 59.56 k | 3.56 k shares | 0.14 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 58.94 k | 4.06 k shares | 0.14 | Common equity | Long | USA |
NVAX Novavax, Inc. | 58.50 k | 6.71 k shares | 0.14 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 58.37 k | 4.19 k shares | 0.14 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 55.96 k | 9.87 k shares | 0.14 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 55.00 k | 3.82 k shares | 0.13 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 53.12 k | 2.97 k shares | 0.13 | Common equity | Long | UK |
AUPH Aurinia Pharmaceuticals Inc. | 53.11 k | 5.99 k shares | 0.13 | Common equity | Long | Canada |
IMCR Immunocore Holdings plc | 52.91 k | 1.62 k shares | 0.13 | Common equity | Long | UK |
ANIP ANI Pharmaceuticals, Inc. | 50.42 k | 881.00 shares | 0.12 | Common equity | Long | USA |
INVA Innoviva, Inc. | 49.85 k | 2.63 k shares | 0.12 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 48.15 k | 1.98 k shares | 0.12 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 45.52 k | 5.72 k shares | 0.11 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 44.65 k | 4.04 k shares | 0.11 | Common equity | Long | Ireland |
COGT Cogent Biosciences, Inc. | 43.62 k | 4.59 k shares | 0.11 | Common equity | Long | USA |
Zymeworks Inc. | 41.99 k | 2.98 k shares | 0.10 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 41.39 k | 1.36 k shares | 0.10 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 40.25 k | 2.86 k shares | 0.10 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 39.88 k | 4.44 k shares | 0.10 | Common equity | Long | USA |
Genmab A/S, ADR
|
37.80 k | 1.76 k shares | 0.09 | Common equity | Long | Denmark |
KNSA Kiniksa Pharmaceuticals, Ltd. | 37.73 k | 1.71 k shares | 0.09 | Common equity | Long | UK |
ABCL AbCellera Biologics Inc. | 37.17 k | 12.35 k shares | 0.09 | Common equity | Long | Canada |
ADPT Adaptive Biotechnologies Corporation | 36.71 k | 6.18 k shares | 0.09 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 36.60 k | 2.26 k shares | 0.09 | Common equity | Long | Ireland |
EOLS Evolus, Inc. | 36.21 k | 2.65 k shares | 0.09 | Common equity | Long | USA |
GRFS Grifols, S.A. | 35.74 k | 5.11 k shares | 0.09 | Common equity | Long | Spain |
CSTL Castle Biosciences, Inc. | 35.46 k | 1.17 k shares | 0.09 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 35.42 k | 3.21 k shares | 0.09 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 35.04 k | 2.54 k shares | 0.09 | Common equity | Long | USA |
ERAS Erasca, Inc. | 33.86 k | 11.84 k shares | 0.08 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings, Inc. | 33.68 k | 5.94 k shares | 0.08 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 33.59 k | 3.55 k shares | 0.08 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 32.74 k | 2.43 k shares | 0.08 | Common equity | Long | USA |
PCRX Pacira BioSciences, Inc. | 32.70 k | 1.93 k shares | 0.08 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 31.80 k | 1.56 k shares | 0.08 | Common equity | Long | UK |
ANAB AnaptysBio, Inc. | 31.50 k | 1.26 k shares | 0.08 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 29.31 k | 2.96 k shares | 0.07 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 27.94 k | 1.07 k shares | 0.07 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 27.85 k | 8.60 k shares | 0.07 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 27.75 k | 8.36 k shares | 0.07 | Common equity | Long | UK |
ABUS Arbutus Biopharma Corporation | 27.39 k | 7.92 k shares | 0.07 | Common equity | Long | Canada |
CVAC CureVac N.V. | 26.97 k | 9.40 k shares | 0.07 | Common equity | Long | Netherlands |
MLYS Mineralys Therapeutics, Inc. | 26.66 k | 2.09 k shares | 0.06 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 26.39 k | 5.62 k shares | 0.06 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 25.93 k | 9.33 k shares | 0.06 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 25.35 k | 2.86 k shares | 0.06 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 24.37 k | 2.41 k shares | 0.06 | Common equity | Long | USA |
Galapagos N.V., ADR
|
23.58 k | 853.00 shares | 0.06 | Common equity | Long | Belgium |
IRWD Ironwood Pharmaceuticals, Inc. | 23.57 k | 6.70 k shares | 0.06 | Common equity | Long | USA |
SVRA Savara Inc. | 23.17 k | 6.90 k shares | 0.06 | Common equity | Long | USA |
GRAL GRAIL, Inc. | 22.65 k | 1.29 k shares | 0.06 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 22.58 k | 5.00 k shares | 0.05 | Common equity | Long | USA |
URGN UroGen Pharma Ltd. | 22.42 k | 1.77 k shares | 0.05 | Common equity | Long | Israel |
YMAB Y-mAbs Therapeutics, Inc. | 22.36 k | 1.88 k shares | 0.05 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 22.04 k | 1.73 k shares | 0.05 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 21.92 k | 1.29 k shares | 0.05 | Common equity | Long | Cayman Islands |
MGTX MeiraGTx Holdings plc | 21.91 k | 3.24 k shares | 0.05 | Common equity | Long | Cayman Islands |
NxStage Medical, Inc. | 21.83 k | 11.43 k shares | 0.05 | Common equity | Long | USA |
SIGA SIGA Technologies, Inc. | 21.78 k | 2.99 k shares | 0.05 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 21.70 k | 8.75 k shares | 0.05 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 20.63 k | 1.13 k shares | 0.05 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 20.60 k | 2.08 k shares | 0.05 | Common equity | Long | USA |
Xeris Pharmaceuticals Inc | 20.46 k | 6.24 k shares | 0.05 | Common equity | Long | USA |
PAHC Phibro Animal Health Corporation | 20.00 k | 856.00 shares | 0.05 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 19.90 k | 2.25 k shares | 0.05 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 19.89 k | 3.55 k shares | 0.05 | Common equity | Long | USA |
OABI OmniAb, Inc. | 19.36 k | 4.95 k shares | 0.05 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 19.06 k | 4.19 k shares | 0.05 | Common equity | Long | USA |
TBPH Theravance Biopharma, Inc. | 19.04 k | 2.06 k shares | 0.05 | Common equity | Long | Cayman Islands |
TERN Terns Pharmaceuticals, Inc. | 18.44 k | 2.96 k shares | 0.04 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals, Inc. | 18.12 k | 1.80 k shares | 0.04 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 17.66 k | 4.48 k shares | 0.04 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 17.02 k | 2.17 k shares | 0.04 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 16.52 k | 5.02 k shares | 0.04 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 15.87 k | 4.39 k shares | 0.04 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 15.79 k | 2.85 k shares | 0.04 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 15.68 k | 2.29 k shares | 0.04 | Common equity | Long | USA |
MXCT MaxCyte, Inc. | 15.64 k | 4.41 k shares | 0.04 | Common equity | Long | USA |
ACIU AC Immune SA | 14.06 k | 4.14 k shares | 0.03 | Common equity | Long | Switzerland |
SAGE Sage Therapeutics, Inc. | 13.94 k | 2.55 k shares | 0.03 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 13.14 k | 1.54 k shares | 0.03 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc. | 12.60 k | 2.45 k shares | 0.03 | Common equity | Long | USA |
ATAI Atai Life Sciences N.V. | 12.52 k | 7.04 k shares | 0.03 | Common equity | Long | Netherlands |
QURE uniQure N.V. | 12.24 k | 2.05 k shares | 0.03 | Common equity | Long | Netherlands |
LXRX Lexicon Pharmaceuticals, Inc. | 12.18 k | 15.15 k shares | 0.03 | Common equity | Long | USA |
ACRS Aclaris Therapeutics, Inc. | 12.17 k | 2.99 k shares | 0.03 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 12.10 k | 3.54 k shares | 0.03 | Common equity | Long | USA |
NAUT Nautilus Biotechnology, Inc. | 11.78 k | 5.26 k shares | 0.03 | Common equity | Long | USA |
Precigen, Inc.
|
11.23 k | 12.05 k shares | 0.03 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 11.05 k | 1.53 k shares | 0.03 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 10.77 k | 2.98 k shares | 0.03 | Common equity | Long | USA |
ALEC Alector, Inc. | 10.56 k | 4.08 k shares | 0.03 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 10.14 k | 10.73 k shares | 0.02 | Common equity | Long | USA |
FULC Fulcrum Therapeutics, Inc. | 10.08 k | 2.62 k shares | 0.02 | Common equity | Long | USA |